Publications - 'C'
Publications 1576 - 1600 de 2875
| Titre | DOI |
|---|---|
|
Comparative analysis of how immune sensitization is defined prior to lung transplantation N. Chin; M. Paraskeva; E. Paul; L. Cantwell; B. Levvey; T. Williams; G. Snell; G. Westall 2015 |
10.1016/j.humimm.2015.09.025 |
|
Comparative Analysis of Prothrombin Complex Concentrate and Fresh Frozen Plasma in Coronary Surgery F. Biancari; V.G. Ruggieri; A. Perrotti; R. Gherli; T. Demal; I. Franzese; M. Dalen; G. Santarpino; A.S. Rubino; D. Maselli; A. Salsano; F. Nicolini; M. Saccocci; G. Gatti; S. Rosato; P. D'Errigo; E.M. Kinnunen; M. De Feo; T. Tauriainen; F. Onorati; G. Mariscalco 2019 |
10.1016/j.hlc.2018.10.025 |
|
Comparative analysis of stimulated Brillouin scattering at 2 mu m in various infrared glass-based optical fibers M. Deroh; J.C. Beugnot; K. Hammani; C. Finot; J. Fatome; F. Smektala; H. Maillotte; T. Sylvestre; B. Kibler 2020 |
10.1364/JOSAB.401252 |
|
Comparative assessment of a foam-based method for ISCO of coal tar contaminated unsaturated soils I. Bouzid; J. Maire; N. Fatin-Rouge 2019 |
10.1016/j.jece.2019.103346 |
|
Comparative assessment of a foam-based oxidative treatment of hydrocarbon-contaminated unsaturated and anisotropic soils I. Bouzid; J. Maire; N. Fatin-Rouge 2019 |
10.1016/j.chemosphere.2019.05.295 |
|
Comparative benefit and cost-effectiveness of mailed-out faecal immunochemical tests vs collection at the general practitioner E.F.P. Peterse; C.B. Osoro; M. Bardou; I. Lansdorp-Vogelaar 2021 |
10.1111/apt.16317 |
|
Comparative binding to DR4 and DR5 receptors of TRAIL and BNNTs/PAHE/mPEG-DSPE/TRAIL nanoparticles Y.Claude Guillaume; C. Andre 2017 |
10.1002/jmr.2611 |
|
Comparative clinical efficacy of alemtuzumab and ocrelizumab in patients with relapsing-remitting multiple sclerosis: Number needed to treat analyses G. Comi; A. Boster; R. Alroughani; R. Berkovich; G. Izquierdo; D. Kantor; C. Laganke; V. Limmroth; R. Macdonell; T. Moreau; B. Sharrack; H. Wiendl; B. van Wijmeersch; D.H. Margolin; K. Thangavelu; M. Melanson; M.S. Freedman 2017 |
|
|
Comparative clinical efficacy of alemtuzumab and ocrelizumab in patients with relapsing-remitting multiple sclerosis: Number needed to treat analyses G. Comi; A. Boster; R. Alroughani; R. Berkovich; G. Izquierdo; D. Kantor; C. Laganke; V. Limmroth; R. Macdonell; T. Moreau; B. Sharrack; H. Wiendl; B. van Wijmeersch; D.H. Margolin; K. Thangavelu; M. Melanson; M.S. Freedman 2017 |
|
|
Comparative clinical efficacy of alemtuzumab and ocrelizumab in patients with relapsing-remitting multiple sclerosis: Number needed to treat analyses G. Comi; A. Boster; R. Alroughani; R. Berkovich; G. Izquierdo; D. Kantor; C. Laganke; V. Limmroth; R. Macdonell; T. Moreau; B. Sharrack; H. Wiendl; B. van Wijmeersch; D.H. Margolin; K. Thangavelu; M. Melanson; M.S. Freedman 2017 |
|
|
Comparative dose levels between CT-scanner and slot-scanning device (EOS system) in pregnant women pelvimetry A. Ben Abdennebi; S. Aubry; L. Ounalli; M.S. Fayache; E. Delabrousse; Y. Petegnief 2017 |
10.1016/j.ejmp.2016.12.008 |
|
Comparative effect of inorganic N on plant growth and N-2 fixation of ten legume crops: towards a better understanding of the differential response among species M. Guinet; B. Nicolardot; C. Revellin; V. Durey; G. Carlsson; A.S. Voisin 2018 |
10.1007/s11104-018-3788-1 |
|
COMPARATIVE EFFECTIVENESS AND MEDICAL COST OF DABIGATRAN VERSUS VITAMIN K ANTAGONISTS FROM ENGEL 2: A FRENCH NATIONWIDE COHORT OF 100,000 PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION P. Blin; G. de Pouvourville; Y. Cottin; C. Dureau-Pournin; A. Abouelfath; R. Lassalle; J. Benichou; C. Droz-Perroteau; P. Mismetti; N. Moore 2017 |
|
|
Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation P. Blin; C. Dureau-Pournin; Y. Cottin; J. Benichou; P. Mismetti; A. Abouelfath; R. Lassalle; C. Droz; N. Moore 2019 |
10.1002/cpt.1318 |
|
Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach L. Cuzin; P. Pugliese; C. Allavena; C. Katlama; L. Cotte; A. Cheret; A. Cabie; D. Rey; C. Chirouze; F. Bani-Sadr; P. Flandre; D.'A.I.D.Sstudy Grp 2015 |
10.1097/MD.0000000000001668 |
|
Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC). M.D. Galsky; L.Christine Harshman; S.J. Crabb; Y.N. Wong; E.Y. Yu; S. Chowdhury; T. Powles; S.Kumar Pal; E.L. Moshier; S. Ladoire; S.A. Hussain; N. Agarwal; U.N. Vaishampayan; F. Recine; D. Berthold; A. Necchi; C. Theodore; M.I. Milowsky; J. Bellmunt; J.E. Rosenberg; R.I.S.C. Investigators 2014 |
10.1200/jco.2014.32.15_suppl.4512 |
|
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer M.D. Galsky; S.K. Pal; S. Chowdhury; L.C. Harshman; S.J. Crabb; Y.N. Wong; E.Y. Yu; T. Powles; E.L. Moshier; S. Ladoire; S.A. Hussain; N. Agarwal; U.N. Vaishampayan; F. Recine; D. Berthold; A. Necchi; C. Theodore; M.I. Milowsky; J. Bellmunt; J.E. Rosenberg; R.Int Study Uroth 2015 |
10.1002/cncr.29387 |
|
Comparative Effects of Di-(2-ethylhexyl)phthalate and Di-(2-ethylhexyl)terephthalate Metabolites on Thyroid Receptors: In Vitro and In Silico Studies N. Kambia; I. Severin; A. Farce; L. Dahbi; T. Dine; E. Moreau; V. Sautou; M.C. Chagnon 2021 |
10.3390/metabo11020094 |
|
Comparative efficacy of fingolimod vs natalizumab A French multicenter observational study L. Barbin; C. Rousseau; N. Jousset; R. Casey; M. Debouverie; S. Vukusic; J. de Seze; D. Brassat; S. Wiertlewski; B. Brochet; J. Pelletier; P. Vermersch; G. Edan; C. Lebrun-Frenay; P. Clavelou; E. Thouvenot; J.P. Camdessanche; A. Tourbah; B. Stankoff; A.Al Khedr; P. Cabre; C. Papeix; E. Berger; O. Heinzlef; T. Debroucker; T. Moreau; O. Gout; B. Bourre; A. Creange; P. Labauge; L. Magy; G. Defer; Y. Foucher; D.A. Laplaud; C.F.S.E.P. Grp; O.F.S.E.P. Grp 2016 |
10.1212/WNL.0000000000002395 |
|
Comparative efficacy of teriflunomide versus dimethyl-fumarate on clinical and MRI outcomes: a two years French multicenter observational D.A. Laplaud; L. Barbin; R. Casey; M. Debouverie; S. Vukusic; P. Labauge; D. Brassat; S. Wiertlewski; J. De Seze; G. Edan; B. Brochet; T. Moreau; E. Berger; P. Clavelou; G. Castelnovo; J. Pelletier; B. Bourre; C. Lubetzki; A. Khedr; P. Vermersch; C. Lebrun-Frenay; G. Defer; A. Tourbah; J.P. Camdessanche; B. Stankoff; C. Labeyrie; I. Patry; A. Creange; O. Gout; O. Heinzlef; O. Casez; L. Magy; A.M. Guennoc; T. Debroucker; C. Nifle; E. Leray; F. Rollot; Y. Foucher; SFSEP; OFSEP 2018 |
|
|
Comparative efficacy of teriflunomide versus dimethyl-fumarate on clinical and MRI outcomes: a two years French multicenter observational D.A. Laplaud; L. Barbin; R. Casey; M. Debouverie; S. Vukusic; P. Labauge; D. Brassat; S. Wiertlewski; J. De Seze; G. Edan; B. Brochet; T. Moreau; E. Berger; P. Clavelou; G. Castelnovo; J. Pelletier; B. Bourre; C. Lubetzki; A. Khedr; P. Vermersch; C. Lebrun-Frenay; G. Defer; A. Tourbah; J.P. Camdessanche; B. Stankoff; C. Labeyrie; I. Patry; A. Creange; O. Gout; O. Heinzlef; O. Casez; L. Magy; A.M. Guennoc; T. Debroucker; C. Nifle; E. Leray; F. Rollot; Y. Foucher; SFSEP; OFSEP 2018 |
|
|
Comparative efficacy of teriflunomide versus dimethyl-fumarate on clinical and MRI outcomes: a two years French multicenter observational D.A. Laplaud; L. Barbin; R. Casey; M. Debouverie; S. Vukusic; P. Labauge; D. Brassat; S. Wiertlewski; J. De Seze; G. Edan; B. Brochet; T. Moreau; E. Berger; P. Clavelou; G. Castelnovo; J. Pelletier; B. Bourre; C. Lubetzki; A. Khedr; P. Vermersch; C. Lebrun-Frenay; G. Defer; A. Tourbah; J.P. Camdessanche; B. Stankoff; C. Labeyrie; I. Patry; A. Creange; O. Gout; O. Heinzlef; O. Casez; L. Magy; A.M. Guennoc; T. Debroucker; C. Nifle; E. Leray; F. Rollot; Y. Foucher; SFSEP; OFSEP 2018 |
|
|
Comparative efficacy of teriflunomide versus dimethyl-fumarate: a French multicenter observational study from the french national OFSEP cohort D.A. Laplaud; L. Barbin; R. Casey; M. Debouverie; S. Vukusic; P. Labauge; D. Brassat; S. Wiertlewski; J. De Ssze; G. Edan; B. Brochet; T. Moreau; E. Berger; P. Clavelou; G. Castelnovo; J. Ciron; J. Pelletier; B. Bourre; C. Lubetzki; A. Al-Khedr; P. Vermersch; C. Lebrun-Frenay; G. Defer; A. Tourbah; J.P. Camdessanch; B. Stankoff; C. Labeyrie; I. Patry; A. Creange; O. Gout; O. Heinzlef; O. Casez; L. Magy; A.M. Guennoc; T. Debroucker; C. Nifle; C. Dupel-Pottier; E. Leray; F. Rollot; Y. Foucher; SFSEP; OFSEP 2017 |
|
|
Comparative efficacy of teriflunomide versus dimethyl-fumarate: a French multicenter observational study from the french national OFSEP cohort D.A. Laplaud; L. Barbin; R. Casey; M. Debouverie; S. Vukusic; P. Labauge; D. Brassat; S. Wiertlewski; J. De Ssze; G. Edan; B. Brochet; T. Moreau; E. Berger; P. Clavelou; G. Castelnovo; J. Ciron; J. Pelletier; B. Bourre; C. Lubetzki; A. Al-Khedr; P. Vermersch; C. Lebrun-Frenay; G. Defer; A. Tourbah; J.P. Camdessanch; B. Stankoff; C. Labeyrie; I. Patry; A. Creange; O. Gout; O. Heinzlef; O. Casez; L. Magy; A.M. Guennoc; T. Debroucker; C. Nifle; C. Dupel-Pottier; E. Leray; F. Rollot; Y. Foucher; SFSEP; OFSEP 2017 |
|
|
Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study D.A. Laplaud; L. Barbin; C. Rousseau; N. Jousset; R. Casey; M. Debouverie; S. Vukusic; J. De Seze; D. Brassat; S. Wiertlewski; B. Brochet; J. Pelletier; P. Vermersch; G. Edan; C. Lebrun-Frenay; P. Clavelou; E. Thouvenot; J.P. Camdessanche; A. Tourbah; B. Stankoff; A. Khedr; P. Cabre; C. Papeix; E. Berger; O. Heinzlef; T. Debroucker; T. Moreau; O. Gout; B. Bourre; A. Creange; P. Labauge; L. Magy; G. Defer; Y. Foucher; OFSEP; SFSEP 2015 |